As New Technologies are Incorporated into Stent Design, Frequent Upheavals in the Cardiovascular Devices Market Leadership are Likely to Occur through 2008.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c31541) has announced the addition of Cardiovascular Devices Pipeline Analysis: Innovation and Consolidation Intensify in·ten·si·fy v. in·ten·si·fied, in·ten·si·fy·ing, in·ten·si·fies v.tr. 1. To make intense or more intense: Competition to their offering. The treatment of cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease (CVD CVD Cardiovascular disease, see there ) represents a large and sustainable market growth opportunity for cardiovascular device companies. In 2003, the worldwide cardiovascular device market was estimated at $16.6 billion. High-growth opportunities within the cardiovascular market include cardiac rhythm management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. (CRM (Customer Relationship Management) An integrated information system that is used to plan, schedule and control the presales and postsales activities in an organization. ) and coronary coronary /cor·o·nary/ (kor´o-nar?e) encircling like a crown; applied to vessels, ligaments, etc., especially to the arteries of the heart, and to pathologic involvement of them. cor·o·nar·y adj. stents--primarily drug-eluting stents In cardiology, a drug-eluting stent is a stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents scar-tissue–like growth that, together with clots (thrombus), could otherwise block the stented (DES). These two product segments, which represent approximately two-thirds of the cardiovascular device market, will continue to grow throughout the decade and into the future as a result of many factors. These factors include the continued expansion of indications appropriate for use of CRM products, the launch of improved CRM and DES products that allow patients to be treated earlier in the disease process and thereby allow access to larger patient populations, and the lack of viable competing alternative pharmaceutical or other treatments. This report examines the key devices driving the adoption of new cardiovascular procedures. The focus is on leading companies and device categories that address cardiovascular disease, specifically coronary disease. It also discusses the potential impact of emerging therapeutic trends and products. Key questions addressed: --Which companies are the major players in the cardiovascular device market? --Which companies are the emerging players developing cardiovascular devices? --What is the potential impact of industry consolidation on both major and emerging players developing cardiovascular devices? --What is the commercial outlook for the cardiovascular devices market? Companies mentioned: --Medtronic --Johnson & Johnson --Boston Scientific --St. Jude Medical --Abbott Laboratories --Sorin Group --Biotronik --Guidant For more information visit http://www.researchandmarkets.com/reports/c31541 Source: Decision Resources |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion